UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
(Check one): |X| Form 10-KSB | | Form 20-K | | Form 10-QSB | | Form N-SAR
For Period Ended: December 31, 2003
-----------------------------------
| | Transition Report on Form 10-K
| | Transition Report on Form 20-K
| | Transition Report on Form 11-K
| | Transition Report on Form 10-Q
| | Transition Report on Form N-SAR
For the Transition Period Ended:-------------------------------
--------------------------------------------------------------------------------
Read Instruction (on back page) Before Preparing Form. Please Print or Type.
Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.
--------------------------------------------------------------------------------
If the notification relates to a portion of the filing checked above, identify
the Items(s) to which the notification relates:
--------------------------------------------------------------------------------
PART I - REGISTRANT INFORMATION
OraLabs Holding Corp.
--------------------------------------------------------------------------------
Full Name of Registrant
--------------------------------------------------------------------------------
Former Name if Applicable
18685 East Plaza Drive
--------------------------------------------------------------------------------
Address of Principal Executive office (Street and Number)
Parker, Colorado 80134
--------------------------------------------------------------------------------
City, State and Zip Code
PART II - RULES 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)
(a) The reason described in reasonable detail in Part III of this
form could not be eliminated without unreasonable effort or
expense
|X| (b) The subject annual report, semi-annual report, transition report
on Form 10-KSB, Form 20-F, Form 11-K or Form N-SAR, or portion
thereof, will be filed on or before the fifteenth calendar day
following the prescribed due date; or the subject quarterly
report of transition report on Form 10-Q, or portion thereof will
be filed on or before the fifth calendar day following the
prescribed due date; and
(c) The accountant's statement or other exhibit required by Rule
12b-25(c) has been attached if applicable.
PART III - NARRATIVE
State below in reasonable detail why forms 10-K, 20-F, 11-K, 10-Q, N-SAR, or the
transition report or portion thereof, could not be filed within the prescribed
time period.
(Attach Extra Sheets if Needed)
As a result of delays in responding to the auditors and gathering the data
necessary to finalize the financial statements and accompanying notes of the
Registrant's Form 10-KSB, the report on Form 10- KSB could not be timely filed
without unreasonable effort or expense. The Registrant believes that the Form
10- KSB will be filed within the extension period.
PART IV - OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification
Douglas B. Koff (303) 861-1166
------------------------------- --------------- ----------------------
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 or Section 30 of the Investment Company Act
of 1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report(s) been filed? If answer is no,
identify report(s). Yes |X| No | |
--------------------------------------------------------------------------------
(3) Is it anticipated that any significant change in results of operations from
the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion
thereof? Yes |X| No | |
If so, attach an explanation of the anticipated change, both narratively
and quantitatively, and, if appropriate, state the reasons why a reasonable
estimate of the results cannot be made. (See attachment)
--------------------------------------------------------------------------------
OraLabs Holding Corp.
------------------------------------------------
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.
Date March 31, 2004 By /s/ Gary H. Schlatter
----------------------------- ---------------------------
INSTRUCTION: The form may be signed by an executive officer of the registrant or
by any other duly authorized representative. The name and title of the person
signing the form shall be typed or printed beneath the signature. If the
statement is signed on behalf of the registrant by an authorized representative
(0ther than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.
__________________________________ATTENTION_____________________________________
Intentional misstatements or omissions of fact constitute Federal Criminal
Violations (See 18 U.S.C. 1001).
________________________________________________________________________________
ATTACHMENT TO FORM 12b-25
(In this attachment, the numbers stated for 2003 are preliminary, as the
year-end audit is not completed)
Revenues in year 2003 decreased approximately $80,880 or less than 1% from
$14,149,100 in year 2002 to approximately $14,068,220 in year 2003.
Loss. In year 2003 the Company had an approximate loss of $143,041, compared to
net income of $431,932 in year 2002 (a difference of approximately $574,973).
The Company in year 2003 experienced approximately $747,782 in non-ordinary
costs with an impact to net income of approximately $456,147. Approximately
$302,753 was for write off of leasehold improvements for the two Englewood, CO
facilities, one of which was vacated in November, 2003 and the other in
February, 2004. Approximately $311,478 was for venture start-up costs related to
the acquisition of a lip balm company and to start a manufacturing venture
abroad. Approximately $133,552 was for moving expenses related to the relocation
from the two Englewood, Colorado facilities to the Parker, Colorado facility.